Mostrar registro simples

dc.contributor.authorColonetti, Karinapt_BR
dc.contributor.authorSantos, Bruna Bento dospt_BR
dc.contributor.authorNalin, Tatiélept_BR
dc.contributor.authorSouza, Carolina Fischinger Moura dept_BR
dc.contributor.authorTriplett, Eric W.pt_BR
dc.contributor.authorDobbler, Priscila Caroline Thiagopt_BR
dc.contributor.authorSchwartz, Ida Vanessa Doederleinpt_BR
dc.contributor.authorRoesch, Luiz Fernando Wurdigpt_BR
dc.date.accessioned2021-06-22T04:25:28Zpt_BR
dc.date.issued2019pt_BR
dc.identifier.issn1932-6203pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/222532pt_BR
dc.description.abstractIntroduction The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. Objectives The primary objective of this study was to investigate associations between GSD and the gut microbiota. Methods Twenty-four GSD patients on treatment with uncooked cornstarch (UCCS), and 16 healthy controls had their faecal microbiota evaluated through 16S rRNA gene sequencing. Patients and controls were ≥3 years of age and not on antibiotics. Faecal pH, calprotectin, mean daily nutrient intake and current medications were recorded and correlated with gut microbiome. Results Patients’ group presented higher intake of UCCS, higher prevalence of IBD (n = 04/24) and obesity/overweight (n = 18/24) compared to controls (n = 0 and 06/16, respectively). Both groups differed regarding diet (in patients, the calories’ source was mainly the UCSS, and the intake of fat, calcium, sodium, and vitamins was lower than in controls), use of angiotensin-converting enzyme inhibitors (patients = 11, controls = 0; p-value = 0.001) multivitamins (patients = 22, controls = 01; p-value = 0.001), and mean faecal pH (patients = 6.23; controls = 7.41; p = 0.001). The GSD microbiome was characterized by low diversity and distinct microbial structure. The operational taxonomic unit (OTU) abundance was significantly influenced by faecal pH (r = 0.77; p = 6.8e-09), total carbohydrate (r = -0.6; p = 4.8e-05) and sugar (r = 0.057; p = 0.00013) intakes. Conclusions GSD patients presented intestinal dysbiosis, showing low faecal microbial diversity in comparison with healthy controls. Those findings might be due to the disease per se, and/or to the different diets, use of UCSS and of medicines, and obesity rate found in patients. Although the main driver of these differences is unknown, this study might help to understand how the nutritional management affects GSD patients.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofPLoS one. San Francisco. Vol. 14, no. 4 (Apr. 2019), e0214582, 17 p.pt_BR
dc.rightsOpen Accessen
dc.subjectGlicogêniopt_BR
dc.subjectDisbiosept_BR
dc.titleHepatic glycogen storage diseases are associated to microbial dysbiosispt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001107501pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples